Durgical
EN
Open the app

After an abnormal cervical screening result: triage, cytology categories and colposcopy

  • Approach to a problem

An abnormal screening result is common and almost never cancer. Knowing what each result means stops both panic and a missed high-grade lesion.

Updated

See it in 3D: Cervix · Vaginal fornix · Vagina

What it is

Cervical screening sorts women by their risk of a high-grade precancer (CIN 2–3) or cancer. A positive high-risk HPV test says the cause is present; it is then triaged, usually with cytology (and HPV 16/18 genotyping where available), to decide who needs colposcopy now and who can simply be retested. Cytology is reported with the Bethesda system: ASC-US and LSIL are low-grade; ASC-H and HSIL point to a high-grade lesion; AGC means abnormal glandular cells, which can come from the endocervix or the endometrium. Colposcopy looks at the cervix magnified after acetic acid and Lugol's iodine, judges the transformation zone, and takes biopsies of the worst area. High-grade lesions are treated by ablation or excision of the transformation zone; low-grade ones are usually watched, because most regress.

Red flags

  • A visible cervical lesion, contact bleeding or postcoital bleeding needs examination and referral whatever the screening result.
  • HSIL or ASC-H: colposcopy in every case, even if the HPV test is negative.
  • AGC: colposcopy with endocervical sampling, plus endometrial sampling from about 35 years or with abnormal bleeding or other endometrial risk; never just repeat cytology.
  • Atypical vessels, a raised or ulcerated surface, or a lesion going up the canal out of sight at colposcopy: suspect invasion; biopsy and excise rather than ablate.
  • Colposcopy and biopsy findings that disagree (high-grade cytology, normal colposcopy): review the slides and consider diagnostic excision.
  • Pregnant with suspected invasion: biopsy is safe and must not be deferred.

Step-by-step approach

  1. Read the result as a risk: HPV status, genotype (16/18 carries the highest risk), cytology category and any previous abnormal result.
  2. HPV-positive with normal cytology and no 16/18: repeat HPV testing in about a year as the route sets; colposcopy if it persists or triage is abnormal.
  3. HPV 16/18 positive, ASC-US or LSIL with positive HPV: refer to colposcopy.
  4. ASC-H, HSIL or AGC: colposcopy whatever the HPV result; add endocervical and, when indicated, endometrial sampling for AGC.
  5. At colposcopy: apply acetic acid and Lugol's iodine, classify the transformation zone (fully visible or not) and biopsy the most abnormal areas.
  6. CIN 1 (low grade): usually watch with repeat testing, because most regress within 1 to 2 years.
  7. CIN 2–3: treat the transformation zone; ablation if it is fully visible and no invasion or glandular disease is suspected, otherwise excision.
  8. After treatment: HPV-based test of cure at about 6 to 12 months; routine screening only after a negative result.

Result → risk → next step

ResultWhat it meansRisk of high-grade lesionNext step
HPV negativeNo high-risk HPV detectedVery lowRoutine screening (every 5 years in Colombia from 30)
HPV positive, normal cytologyInfection without visible cell change; most clearLowRepeat HPV test in about a year; colposcopy if HPV 16/18 or it persists
ASC-USAtypical squamous cells of undetermined significanceLow (higher if HPV positive)HPV test (reflex); colposcopy if positive
LSILLow-grade lesion: the visible footprint of HPV infectionLow, about 1 in 25 if HPV positiveColposcopy (from 25); under 25, repeat cytology in a year
ASC-HAtypical squamous cells, cannot exclude HSILModerate, about 1 in 4Colposcopy, whatever the HPV result
HSILHigh-grade lesion likelyHigh, about half have CIN 3 or worseColposcopy; see-and-treat excision is acceptable in non-pregnant women from 25
AGCAbnormal glandular cells (endocervix or endometrium)Uncertain, but includes adenocarcinoma and endometrial cancerColposcopy, endocervical sampling and, when indicated, endometrial biopsy
Positive visual inspection (acetic acid or Lugol)Acetowhite or iodine-negative area at the transformation zoneModerateAblation in the same visit if eligible; refer if large, in the canal or suspicious

Keys to the differential

  • Colposcopy chain: acetic acid briefly dehydrates and clumps proteins in cells with large nuclei → abnormal epithelium turns white → the denser, sharper and quicker the whiteness, the higher the grade; mosaic and coarse punctation add weight, atypical vessels suggest cancer.
  • Lugol's iodine stains glycogen-rich normal squamous epithelium brown; dysplastic or columnar epithelium stays mustard yellow, which outlines the lesion before biopsy or ablation.
  • The transformation zone is where columnar meets squamous epithelium and where nearly all lesions arise. If its upper limit is out of sight inside the canal (common after menopause), ablation cannot reach the whole zone, so excision is needed.
  • Ablation (thermal or cryotherapy) destroys tissue and gives no specimen; excision (LLETZ, or a cold-knife cone) gives a specimen with margins, at the cost of more cervical tissue and a higher later preterm birth risk.
  • Women under 25: lesions, even CIN 2, often regress and excision weakens the cervix, so observation is preferred where follow-up is reliable.
  • Pregnancy: cytology, HPV testing, colposcopy and biopsy are safe, but endocervical curettage is not done; CIN is reassessed and treated after birth unless invasion is suspected.
  • Vaginal intraepithelial neoplasia (VaIN): HPV-related, mostly in the upper vagina, often after hysterectomy for CIN or with immunosuppression; it is found by colposcopy of the vagina with Lugol's iodine and treated by excision, laser or topical therapy.

Next step / Initial management

  • Low risk (HPV positive with normal or low-grade triage, no 16/18): repeat HPV test in about a year; explain that most infections clear.
  • Refer to colposcopy: HPV 16/18, persistent HPV, ASC-US or LSIL with positive HPV, and every ASC-H, HSIL and AGC.
  • Visual inspection programme (Colombia, 30 to 50 years in hard-to-reach areas): ablate in the same visit when eligible; refer lesions that are large, extend into the canal or look like cancer.
  • CIN 2–3 confirmed: ablation or excision by a trained colposcopist; HPV-based test of cure afterwards.
  • Refer at once to gynaecological oncology any suspected invasion, adenocarcinoma in situ or glandular abnormality without a clear explanation.

Common traps

  • Repeating cytology for AGC: glandular abnormalities hide adenocarcinoma and endometrial cancer; they need colposcopy and endocervical and endometrial sampling, not another smear.
  • A negative HPV test cancels an HSIL result: high-grade cytology goes to colposcopy whatever the HPV result, because tests miss some lesions.
  • LSIL means a precancer that must be cut out: LSIL is the footprint of HPV and usually regresses; treatment is for confirmed CIN 2–3.
  • Ablating when the transformation zone is not fully visible: part of the zone is left untreated, and a hidden lesion or early cancer can be missed; excise instead.
  • Postponing a biopsy because she is pregnant: biopsy is safe in pregnancy; only treatment of precancer is deferred until after birth.

Test yourself

Think of the answer, then tap the question to see it.

A 29-year-old has HSIL on cytology and a negative HPV test. What is the next step?

Colposcopy with biopsy anyway: high-grade cytology carries a high risk whatever the HPV result, and tests can miss lesions.

A 42-year-old with heavy irregular periods has AGC on cytology. Which tests does she need?

Colposcopy with endocervical sampling and an endometrial biopsy, because the abnormal glandular cells may come from the endocervix or the endometrium; repeat cytology alone is wrong.

Why is ablation not suitable when the transformation zone is not fully visible?

Ablation treats only what can be seen and leaves no specimen, so part of the zone, and any hidden lesion or early cancer, could be left behind; excision is needed.

A woman 20 weeks pregnant has HSIL and colposcopy suggests a high-grade lesion without signs of invasion. What do you do?

Biopsy if there is any doubt about invasion, avoid endocervical curettage, and reassess with colposcopy after birth, when the lesion is treated if it persists.

Add to my cards (4)

Elsewhere in DurgiPedia

Connections

← All of obstetrics and gynaecology

Educational content; it does not replace assessment by a doctor or your institution's protocols, and it contains no doses. For heavy bleeding, a severe headache or blurred vision, a seizure, fever, strong abdominal pain or fewer baby movements, go to an emergency department at once.

Sources: WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention (World Health Organization, 2021); Resolución 3280 de 2018: lineamientos técnicos y operativos de la Ruta de Promoción y Mantenimiento de la Salud y de la Ruta Materno Perinatal (Ministerio de Salud y Protección Social de Colombia, 2018); Abnormal Papanicolaou Smear (StatPearls (NCBI Bookshelf), 2026); Colposcopy (StatPearls (NCBI Bookshelf), 2023); High-Grade Squamous Intraepithelial Lesion of the Cervix (StatPearls (NCBI Bookshelf), 2023); Atypical Glandular Cells (AGS) (StatPearls (NCBI Bookshelf), 2022); Cervical Dysplasia (StatPearls (NCBI Bookshelf), 2023); Vaginal Cancer (StatPearls (NCBI Bookshelf), 2023).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.